HTG EdgeSeq Oncology Biomarker Panel

HTG Molecular Diagnostics has launched the HTG EdgeSeq Oncology Biomarker Panel for profiling the expression of more than 2,500 oncology-related biomarkers. The panel runs on the fully automated HTG EdgeSeq system, and couples the company's proprietary nuclease protection chemistry with next-generation sequencing. According to the company, the new panel analyzes a comprehensive set of biomarkers for profiling tumor tissues, analyzing cancer pathways, and identifying new biomarkers across both solid tumors and hematolymphoid neoplasms.